Mitochondrial abnormalities in patients with primary open-angle glaucoma

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 6, 2006, Pages 2533-2541

  Abu Amero, Khaled K ^a   Morales, Jose ^b   Bosley, Thomas M ^a,b  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; PURINE; PYRIMIDINE; CYTOSKELETON PROTEIN; EYE PROTEIN; GLYCOPROTEIN; MYOCILIN; OPTN PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TRABECULAR MESHWORK-INDUCED GLUCOCORTICOID RESPONSE PROTEIN; TRANSCRIPTION FACTOR IIIA;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA SEQUENCE; FEMALE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC CODE; GENETIC POLYMORPHISM; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MALE; MITOCHONDRIAL RESPIRATION; NERVE FIBER; OPEN ANGLE GLAUCOMA; OPTIC NERVE; OXIDATIVE STRESS; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; RETINA GANGLION CELL; RISK FACTOR; GENETICS; INTRAOCULAR PRESSURE; METABOLISM; MIDDLE AGED; MITOCHONDRION;

ADULT; AGED; AGED, 80 AND OVER; CYTOSKELETAL PROTEINS; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX I; EYE PROTEINS; FEMALE; GLAUCOMA, OPEN-ANGLE; GLYCOPROTEINS; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; MITOCHONDRIA; MITOCHONDRIAL DISEASES; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; RISK FACTORS; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTOR TFIIIA;

EID: 33745675536     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-1639     Document Type: Article

References (36)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
2. Gherghel D, Hosking SL, Orgul S. Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma. Surv Ophthalmol. 2004;49:491-508.
3. Spaeth GL. A new classification of glaucoma including focal glaucoma. Surv Ophthalmol. 1994;38(suppl):S9 -S17.
4. Fingert JH, Heon E, Liebmann JM, et al. Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet. 1999;8:899-905.
5. Alward WL, Kwon YH, Kawase K, et al. Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucoma. Am J Ophthalmol. 2003;136:904-910.
6. Nickells RW. Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death. Surv Ophthalmol. 1999;43(suppl 1):S151-S161.
7. Forbes CS. Iceland: Its Volcanoes, Geysers, and Glaciers. London: J. Murray; 1860:335.
8. Quigley HA. Neuronal death in glaucoma. Prog Retin Eye Res. 1999;18:39-57.
9. Howell N. LHON and other optic nerve atrophies: the mitochondrial connection. Dev Ophthalmol. 2003;37:94-108.
10. Alexander C, Votruba M, Pesch UE, et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet. 2000:26:211-215.
11. Abu-Amero KK, Bosley TM. Detection of mitochondrial respiratory dysfunction in circulating lymphocytes using resazurin. Arch Pathol Lab Med. 2005;129:1295-1298.
12. Opial D, Boehnke M, Tadesse S, et al. Leber's hereditary optic neuropathy mitochondrial DNA mutations in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 2001;239:437-440.
13. Bosley TM, Abu-Amero KK, Ozand PT. Mitochondrial DNA nucleotide changes in non-arteritic ischemic optic neuropathy. Neurology. 2004;63:1305-1308.
14. Brandon MC, Lott M, Nguyen KC, et al. MITOMAP: A human mitochondrial genome database-2004 update. URL: http://www-.mitomap.org. Nucl Acids Res. 2005;33:D611-D613.
15. Chinnery PF, Howell N, Andrews RM, Turnbull DM. Mitochondrial DNA analysis: polymorphisms and pathogenicity. J Med Genet. 1999;36:505-510.
16. Sunyaev S, Ramensky V, Koch I, et al. Prediction of deleterious human alleles. Hum Mol Genet. 2001;10:591-597.
17. Ng PC, Henikoff S. Accounting for human polymorphisms predicted to affect protein function. Genome Res. 2002;12:436-446.
18. Fahy E, Nazarbaghi R, Zomorrodi M, et al. Multiplex fluorescence-based primer extension method for quantitative mutation analysis of mitochondrial DNA and its diagnostic application for Alzheimer's disease. Nucl Acids Res. 1997;25:3102-3109.
19. Kao SH, Chao HT, Liu HW, et al. Sperm mitochondrial DNA depletion in men with asthenospermia. Fertil Steril. 2004;82:66-73.
20. Morrissey SP, Borruat FX, Miller DH, et al. Bilateral simultaneous optic neuropathy in adults: clinical, imaging, serological, and genetic studies. J Neurol Neurosurg Psychiatry. 1995;58:70-74.
21. Mackey DA, Craig JE. Predictive DNA testing for glaucoma: reality in 2003. Ophthalmol Clin North Am. 2003;16:639-645.
22. Lee HC, Wei YH. Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochem Cell Biol. 2005;37:822-834.
23. Newman NJ. From genotype to phenotype in Leber hereditary optic neuropathy: still more questions than answers. J Neuroophthalmol. 2002;22:257-261.
24. Singh KK. Mitochondrial dysfunction is a common phenotype in aging and cancer. Ann NY Acad Sci. 2004;1019:260-264.
25. Tielsch JM, Katz J, Sommer A, et al. Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey. Arch Ophthalmol. 1994;112:69-73.
26. Barron MJ, Griffiths P, Turnbull DM, et al. The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head. Br J Ophthalmol. 2004;88:286-290.
27. Lamminen T, Huoponen K, Sistonen P, et al. mtDNA haplotype analysis in Finnish families with leber hereditary optic neuroretinopathy. Eur J Hum Genet. 1997;5:271-279.
28. Fauser S, Luberichs J, Besch D, Leo-Kottler B. Sequence analysis of the complete mitochondrial genome in patients with Leber's hereditary optic neuropathy lacking the three most common pathogenic DNA mutations. Biochem Biophys Res Commun. 2002;295:342-347.
29. Hofmann S, Bezold R, Jaksch M, et al. Analysis of the mitochondrial DNA from patients with Wolfram (DIDMOAD) syndrome. Mol Cell Biochem. 1997;174:209-213.
30. Delettre C, Lenaers G, Griffoin JM, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet. 2000;26:207-210.
31. Tatton WG, Chalmers-Redman RM, Sud A, et al. Maintaining mitochondrial membrane impermeability: an opportunity for new therapy in glaucoma? Surv Ophthalmol. 2001;45(suppl 3):S277-S283; discussion S95-S96.
32. Tezel G, Yang X. Caspase-independent component of retinal ganglion cell death, in vitro. Invest Ophthalmol Vis Sci. 2004;45:4049-4059.
33. Sekiguchi M, Tsuzuki T. Oxidative nucleotide damage: consequences and prevention. Oncogene. 2002;21:8895-8904.
34. Sacca SC, Pascotto A, Camicione P, et al. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch Ophthalmol. 2005;123:458-463.
35. Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res. 2004;23:53-89.
36. Guy J, Qi X, Pallotti F, et al. Rescue of a mitochondrial deficiency causing Leber Hereditary Optic Neuropathy. Ann Neurol. 2002;52:534-542.